Shanghai Wibson Biotechnology: difference between revisions
Diff·revision 6 → 7·08:57, 28 Feb 2025
Difference between revision 6 and revision 7 of Shanghai Wibson Biotechnology. 9 lines changed; the page grew by 979 bytes.
| Revision 6 — 18:22, 19 Feb 2025 CheckSumChase (talk) correct the regional-warehouse list — six sites, not five 4,337 bytes +1,443 | Revision 7 — 08:57, 28 Feb 2025 VerifyVesna (talk) serial comma per PP:MOS 5,316 bytes +979 | ||
|---|---|---|---|
| 4 | | Trading name = SWB | 4 | | Trading name = SWB |
| 5 | | Other designations = SWB Biotech, Shanghai Wibson Biotechnology | 5 | | Other designations = SWB Biotech, Shanghai Wibson Biotechnology |
| + | 6 | <!-- Identity --> | |
| + | 7 | | Founded = 2019 | |
| + | 8 | | Headquarters = Shanghai, China | |
| + | 9 | | Industry = Research-compound supply | |
| + | 10 | | Official site = [https://shanghaiwibsonbiotechnology.net/ Visit SWB at shanghaiwibsonbiotechnology.net] | |
| 6 | }} | 11 | }} |
| 7 | 12 | ||
| ⋮ | ⋮ | ||
| 20 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. | 25 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. |
| 21 | 26 | ||
| + | 27 | == Operations and documentation practice == | |
| + | 28 | Purchaser reports describe conventional practice: lyophilised material in crimped glass vials, batch certificate enclosed, cold pack for the temperature-sensitive lines.{{r|reports}} Certificates in the submitted set report an [[Area percent purity|area percent]] purity and an appearance line as standard; the [[Peptide content|peptide content]] and water determinations that turn that figure into a net mass are issued against a named lot on request, and §Ordering and availability sets out what to quote when asking.{{r|usp1503}} | |
| + | 29 | ||
| 22 | == References == | 30 | == References == |
| 23 | {{reflist}} | 31 | {{reflist}} |
| ⋮ | ⋮ | ||
| 26 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | 34 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> |
| 27 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 35 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| + | 36 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | |
| 28 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 37 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 29 | 38 |